NDC 76329-8261-01 - Lorazepam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76329-8261
- Requested NDC
- 76329-8261-01
- Package NDCs from labels
- 76329-8261-1, 76329-8261-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-03-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorazepam - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-03-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Lorazepam - International Medication Systems, Limited | International Medication Systems, Limited | 2024-03-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76329-8261-1 | Lorazepam | 10 mL in 1 VIAL | INJECTION | 10 | 13 | |
| 76329-8261-1 | Lorazepam | 10 in 1 CARTON | INJECTION | 10 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 76329-8261 | LORAZEPAM INJECTION [INTERNATIONAL MEDICATION SYSTEMS, LIMITED ] | 13 | Current NDC, Legacy NDC, 2 package rows | 20240306_7dda070d-7809-46c4-8592-eb4e4c509707.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76329-8261-1 | ML - Milliliter | 76329-8261 | 434a2601-7460-488b-b472-386a13aa9343 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Lorazepam | ACTIVE INGREDIENT | O26FZP769L | LORAZEPAM INJECTION [INTERNATIONAL MEDICATION SYSTEMS, LIMITED ] | 2 | |
| Lorazepam | ACTIVE MOIETY | O26FZP769L | LORAZEPAM INJECTION [INTERNATIONAL MEDICATION SYSTEMS, LIMITED ] | 2 | |
| Benzyl Alcohol | INACTIVE INGREDIENT | LKG8494WBH | LORAZEPAM INJECTION [INTERNATIONAL MEDICATION SYSTEMS, LIMITED ] | 2 | |
| Polyethylene glycol 400 | INACTIVE INGREDIENT | B697894SGQ | LORAZEPAM INJECTION [INTERNATIONAL MEDICATION SYSTEMS, LIMITED ] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | Clinical Solutions Wholesale, LLC | c0810422-b732-4c04-97d8-c1521c401ef4 | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | 86630bdd-13ad-4ab5-9e94-fcf2ea2113e1 | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Dr.Harry EYES PROTECTION | POLYETHYLENE GLYCOL 400 1% EYES PROTECTION | Wenzhou Yuyuan Pharmaceutical Co., Ltd. | 5a9fe033-89d3-da62-e063-6294a90a4503 | 2026-09-03 | Warnings | B697894SGQ |
| 0.9% Benzyl Alcohol Solution (Laboratory Use Only) | 0.9% BENZYL ALCOHOL SOLUTION (LABORATORY USE ONLY) | Guangzhou Huanmei Cosmetics Co., Ltd | 5976bde6-0999-ffc4-e063-6394a90aadcf | 2026-08-20 | Warnings | LKG8494WBH |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | 5a02c97d-637d-43f7-803c-afe4381ccc59 | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Leader Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | CARDINAL HEALTH 110, LLC. DBA LEADER | 2ded4bda-b3c3-4521-8701-5c8446fd148b | 2026-08-17 | Warnings | B697894SGQ |
| SYSTANE HYDRATION PF PRESERVATIVE FREE | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 8936f66f-10fe-44ab-a26e-dd8b05dfa997 | 2026-08-10 | Warnings | B697894SGQ |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | 6c5356b1-c199-49ad-bb00-fd67c6691f74 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Leader Lubricant Eye Drops 30ct | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | CARDINAL HEALTH 110, LLC. DBA LEADER | 8df69f2c-40c4-245c-e053-2a95a90a5406 | 2026-08-05 | Warnings | B697894SGQ |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | ed37d304-04cf-43ec-a58d-d72002ff889b | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| LORAZEPAM | LORAZEPAM | Preferred Pharmaceuticals Inc. | 903351ae-1bb0-4ac0-8430-df24cf2eee76 | 2026-07-31 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | be9f8bda-1cd9-40a6-a4da-b5961389fb5b | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lidocaine Plus Pain Relieving | LIDOCAINE HYDROCHLORIDE, BENZYL ALCOHOL | CVS Pharmacy | 49003aac-184c-ae33-e063-6294a90a29c0 | 2026-07-24 | Warnings | LKG8494WBH |
| Lorazepam | LORAZEPAM | ANI Pharmaceuticals, Inc. | 787240e9-67b5-4af3-b16d-7cf314e3f2e3 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Hospira, Inc. | 20140b19-846b-425f-b191-670e17809945 | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | d6364be4-056b-4ebe-83bc-3fc85e8f488c | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | St. Mary's Medical Park Pharmacy | 56093df3-10f6-e747-e063-6294a90a6564 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | St. Mary's Medical Park Pharmacy | 569e8a5a-ddf7-ebbc-e063-6294a90ab7a4 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | b707ecb2-644c-4323-ab0e-7bc5929cd560 | 2026-06-26 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Unit Dose Solutions, Inc. | 5519bba8-9eb7-a3e0-e063-6294a90afd94 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.